Multiparametric MRI helps identify low- and high-grade brain gliomas, reducing risk of inappropriate or delayed surgery.
Multiparametric MR imaging significantly improved discrimination between low- and high-grade brain gliomas, according to a study published in the journal Radiology.
Researchers from Italy undertook a retrospective study to determine how multiparametric MR imaging, taking into account the heterogeneity of the lesions at MR imaging, affected current radiologic reporting methods and grading of brain gliomas.
A total of 118 patients with histologically confirmed brain gliomas were evaluated. The patients had undergone conventional and advanced MR sequences (perfusion-weighted imaging, MR spectroscopy, and diffusion-tensor imaging). Three evaluations were conducted:
The researchers found that there were significant differences in age, relative cerebral blood volume (rCBV) in contrast-enhanced regions (area under the ROC curve [AUC] = 0.937), areas of lowest signal intensity on T2-weighted images, restricted diffusivity regions, and choline/creatine ratio in regions with the lowest signal intensity on T2-weighted images.
“[Discriminant function analysis] (DFA) that included age; rCBV in contrast-enhanced regions, areas of lowest signal intensity on T2-weighted images, and areas of restricted diffusivity; and choline/creatine ratio in areas with lowest signal intensity on T2-weighted images was used to classify 95 percent of patients correctly,” the authors wrote. “Quantitative analysis showed a higher concordance with histologic findings than qualitative and semiquantitative methods (P < .0001).”
The researchers concluded that quantitative multiparametric MR imaging evaluation incorporating heterogeneity at MR imaging significantly improved discrimination between low- and high-grade brain gliomas with a very high AUC. This reduced the risk of inappropriate or delayed surgery.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.